Briles, D.E., Hollingshead, S.K., Swiatlo, E., Brooks-Walter, A., Szalai, A., Virolainen, A., Mcdaniel, L.S., Benton, K. A., White, P., Prellner, K., Hermansson, A., Aerts, P.C., van Dijk, H. and Crain, M.J. (1997) PspA and PspC: Their Potential for Use as Pneumococcal Vaccines. Microbial Drug Resistance, 3, 401-408. http://dx.doi.org/10.1089/mdr.1997.3.401

has been cited by the following article:

• TITLE: Insights into Pneumococcal Pathogenesis and Antibiotic Resistance

  AUTHORS: Eric S. Donkor, Ebenezer V. Badoe

  KEYWORDS: Pneumococcus, Antibiotic Resistance, Virulence, Penicillin, Genome

  JOURNAL NAME: Advances in Microbiology, Vol.4 No.10, August 18, 2014

  ABSTRACT: Since its discovery in 1891, the pneumococcus has been one of the most extensively studied microbes, and was involved in several historical findings such as the discovery of genetic material that was later shown to be DNA. The pneumococcus is part of the normal bacterial flora of the nasopharynx, but can on occasions progress to sterile sites of the body and cause invasive diseases. There are about one million new invasive pneumococcal infections every year, majority of which occur in the developing world where children